The Effectiveness of Dry Needling Compared to Myofascial Decompression Therapy on Upper Trapezius Myofascial Trigger points

Phase 1

• Conditions: Musculoskeletal Diseases

• Registration Number: PACTR202003774700847
• Lead Sponsor: niversity of Johannesburg Health Science Ethics Committee

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-12
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

•Participants must be between the age of 18 and 50 years as degenerative cervical diseases are common among people over the age of 50 and this limits the possibility of degenerative changes in the participant
•Present with active myofascial trigger points, unilateral or bilateral, of the upper trapezius muscle (Trp1 and Trp2).
•The diagnostic criteria of TrPs on examination are:
- A palpable, taut band present in a muscle
- Pain elicited by digital pressure
- A characteristic pattern of referred pain specific to individual muscles
- The occurrence of a LTR as a result of needle insertion
- Limited stretch range of motion
•Must be able to attend all treatments
•Participants cannot be on anti-inflammatories or other drugs which might alter their pain during the study

Exclusion Criteria

•Contra-indicated for Myofascial decompression therapy
•Contra-indicated for myofascial dry needling
•Received any form of treatment which may interfere with the results of the study such as massage therapy, physiotherapy, medications in the form of analgesics or anti-inflammatories.
•Have no active myofascial trigger point in the upper trapezius muscle

Study & Design

• Study Type: Interventional
• Study Design: Not specified